UNSPSC 51142540: Amantadine hydrochloride

This classification denotes an antiviral agent and cation channel blocker with the molecular formula C10H17N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier M6Q1EO9TD0, chemically known as 1-aminotricyclo(3.3.1.1(sup 3,7))decane but more generally known as amantadine hydrochloride, which bears US NIH Compound Identifier 2130. European Medicines Agency schedules Amantadine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00422MIG.

Most nations, for tariff and trade purposes, schedule amantadine hydrochloride under HS 29213000 and SITC 51453. As of Q4 2014, AMANTADINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Amantadine hydrochloride bears US NLM identifiers UMLS ID C0723562 and NCI Concept Code C28818. SMILES: C1[C@@H]2CC3C[C@H]1C[C@](C2)(C3)N.CL.

UNSPSC 51142540 Amantadine hydrochloride is a Commodity code that nominally covers a specific antiviral pharmaceutical, yet recent state and local solicitations tagged under this code show little activity aligned with the medication itself. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026—solicits Naloxone and Safe Drug Deactivation Systems, products unrelated to amantadine hydrochloride. The mismatch suggests either a tagging error in the source or that this code sees minimal relevant state and local procurement activity at present.

Seminole County, the only issuing body represented in recent opportunities under this code, released an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, and a response deadline of July 26, 2023 (note: this deadline appears to be a historical date despite the posting date of June 30, 2026, suggesting a data inconsistency in the source). Bidders must include all shipping and delivery costs, provide unit pricing per line item, meet drug-free workplace and E-Verify requirements, carry specified insurance coverage, and accept a three-month probationary period. The contract carries a two-year initial term with a one-year renewal option and potential FEMA funding, introducing federal compliance obligations. With only one misaligned opportunity and no evidence of broader amantadine hydrochloride procurement across state or local jurisdictions, this code does not represent an active area for business development focus at this time.